Health Condition 1: 1- Obstetrics
Conditions
Interventions
Intervention1: Nalbuphine 0.1ml that is 1 mg with ropivacaine heavy 21mg that is 2.8 ml will be administered intrathecally: Nalbuphine 0.1ml that is 1 mg with ropivacaine heavy 21mg that is 2.8 ml wil
Sponsors
SMSRSharda University sharda hospital greter noida
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients scheduled for abdominal hysterectomy 2.ASA class I and II 3.Age 18-60 years 4.Height-150-170cms 5.BMI
Exclusion criteria
Exclusion criteria: 1. Patient refusal to participate in study. 2. Patient having any spinal deformity. 3. Infection at the site of subarchnoid block. 4. Patient receiving steroids, analgesics and sedatives. 5. Patient having history of endocrine, cardiovascular, renal or CNS disease. 6. Patient having history of chronic pain 7. Patient having history of allergy to study drugs. 8. Patient having psychiatric disorder. 9. Any history of clotting or bleeding disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the duration of postoperative analgesia between the two groups ââ?¬â??(intrathecal hyperbaric Ropivacaine with or without Nalbuphine) Timepoint: 2 to 3 hours post operatively | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare the post operative pain between the two groups. 2. To compare the intraoperative hemodynamic parameters in the two groups. 3. To observe any related side effects in the two groups such as urinary retention,nausea and vomiting,sedation and respiratory depression. 4. To compare the sedation score in the two groups. Timepoint: 2 to 3 hours post operatively | — |
Countries
India
Contacts
Public ContactVidushi Kothari
Sharda hospital
Outcome results
None listed